The University of Chicago Header Logo

Stephen Hanauer

Concepts (947)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Crohn Disease
228
2026
861
27.890
Why?
Colitis, Ulcerative
182
2026
844
19.990
Why?
Inflammatory Bowel Diseases
90
2026
685
15.810
Why?
Gastrointestinal Agents
61
2026
202
12.610
Why?
Antibodies, Monoclonal
76
2026
1422
7.010
Why?
Immunosuppressive Agents
67
2025
1021
6.250
Why?
Anti-Inflammatory Agents, Non-Steroidal
48
2021
255
6.170
Why?
Infliximab
59
2026
170
5.950
Why?
Anti-Inflammatory Agents
50
2020
362
5.920
Why?
Mesalamine
45
2020
91
5.790
Why?
Remission Induction
81
2026
764
4.180
Why?
Tumor Necrosis Factor-alpha
44
2025
712
4.070
Why?
Gastroenterology
14
2020
162
3.960
Why?
Biological Products
14
2025
191
3.680
Why?
Humans
504
2026
98799
3.460
Why?
Biosimilar Pharmaceuticals
6
2025
25
3.390
Why?
Biological Therapy
16
2020
47
3.200
Why?
Adrenal Cortex Hormones
29
2026
308
3.170
Why?
Colitis
13
2024
265
3.090
Why?
Treatment Outcome
139
2026
9806
3.020
Why?
Severity of Illness Index
68
2026
2025
2.910
Why?
Adalimumab
24
2026
94
2.850
Why?
Azathioprine
22
2021
130
2.810
Why?
Double-Blind Method
86
2026
1793
2.630
Why?
Immunologic Factors
14
2021
180
2.560
Why?
Aminosalicylic Acids
29
2016
41
2.420
Why?
Stress Disorders, Post-Traumatic
5
2023
132
2.100
Why?
Adult
208
2026
29698
2.100
Why?
Mercaptopurine
13
2018
53
2.010
Why?
Randomized Controlled Trials as Topic
26
2026
995
2.010
Why?
Ustekinumab
11
2026
55
2.000
Why?
Maintenance Chemotherapy
16
2026
96
1.980
Why?
Antibodies, Monoclonal, Humanized
39
2026
1105
1.870
Why?
Female
224
2026
51997
1.720
Why?
Male
213
2026
47475
1.700
Why?
Janus Kinase Inhibitors
2
2026
39
1.640
Why?
Clinical Trials as Topic
25
2026
1128
1.620
Why?
Sulfasalazine
18
2016
33
1.590
Why?
Middle Aged
157
2026
29642
1.550
Why?
Glucocorticoids
20
2024
371
1.540
Why?
Intestinal Mucosa
25
2020
846
1.540
Why?
Colonoscopy
24
2021
317
1.530
Why?
Arthritis, Rheumatoid
5
2023
190
1.520
Why?
Methotrexate
12
2022
229
1.520
Why?
Drug Therapy, Combination
28
2025
766
1.500
Why?
Antibodies
11
2026
349
1.410
Why?
Colorectal Neoplasms
15
2024
1120
1.410
Why?
Pharmaceutical Preparations
3
2021
109
1.410
Why?
Induction Chemotherapy
12
2023
152
1.380
Why?
Cyclosporine
13
2018
241
1.360
Why?
Drug Monitoring
9
2025
167
1.340
Why?
Smoking
15
2020
676
1.310
Why?
Colectomy
22
2018
211
1.290
Why?
Digestive System Diseases
6
2010
19
1.280
Why?
Injections, Subcutaneous
14
2026
142
1.270
Why?
Diarrhea
9
2021
180
1.200
Why?
Biomedical Research
7
2010
477
1.130
Why?
Heterocyclic Compounds, 3-Ring
2
2026
56
1.130
Why?
Fellowships and Scholarships
2
2020
164
1.110
Why?
Drug Industry
4
2009
57
1.060
Why?
Colon
26
2025
566
1.030
Why?
Pyrimidines
2
2021
416
1.020
Why?
Nicotine
8
2012
218
0.990
Why?
Secondary Prevention
9
2020
194
0.980
Why?
Early Medical Intervention
1
2026
21
0.980
Why?
Quality of Life
27
2026
1904
0.930
Why?
Education, Medical, Graduate
2
2020
455
0.930
Why?
Budesonide
10
2016
46
0.910
Why?
Dose-Response Relationship, Drug
39
2026
1949
0.910
Why?
Drug-Related Side Effects and Adverse Reactions
5
2022
220
0.900
Why?
Immunoglobulin Fab Fragments
10
2014
92
0.890
Why?
United States
37
2024
8387
0.880
Why?
Anti-Infective Agents
8
2013
87
0.880
Why?
Serum
2
2015
26
0.870
Why?
Anemia
1
2026
135
0.860
Why?
Vitamin D
4
2016
287
0.860
Why?
Evidence-Based Medicine
8
2011
483
0.850
Why?
Certolizumab Pegol
11
2016
19
0.850
Why?
Drug Administration Schedule
23
2020
837
0.840
Why?
Safety
9
2021
138
0.840
Why?
Loperamide
4
2008
7
0.840
Why?
Antidiarrheals
4
2008
14
0.830
Why?
Anti-Bacterial Agents
15
2011
885
0.820
Why?
Polyethylene Glycols
10
2014
383
0.810
Why?
Biomarkers
14
2024
2026
0.810
Why?
Health Care Reform
3
2010
79
0.810
Why?
Allopurinol
5
2018
77
0.780
Why?
Semen
2
2022
19
0.770
Why?
Travel
3
2010
80
0.760
Why?
Irritable Bowel Syndrome
3
2008
46
0.760
Why?
Drug Resistance
13
2014
234
0.760
Why?
Nicotinic Agonists
3
2012
74
0.750
Why?
Semen Analysis
1
2022
5
0.730
Why?
Practice Guidelines as Topic
11
2016
1116
0.730
Why?
Risk Assessment
13
2019
2604
0.730
Why?
Placebos
12
2018
210
0.720
Why?
Piperidines
3
2021
177
0.710
Why?
Young Adult
40
2026
7598
0.700
Why?
Precision Medicine
2
2025
512
0.700
Why?
Atrioventricular Block
1
2022
34
0.700
Why?
Europe
9
2023
360
0.680
Why?
Diet, Mediterranean
1
2021
6
0.680
Why?
Pyrroles
2
2021
166
0.680
Why?
Oxadiazoles
5
2024
42
0.680
Why?
Aged
71
2024
21986
0.680
Why?
Gastrointestinal Diseases
4
2024
156
0.670
Why?
Indans
5
2024
42
0.670
Why?
Time Factors
35
2026
5586
0.670
Why?
Prodrugs
4
2013
53
0.660
Why?
Colonic Neoplasms
11
2018
592
0.660
Why?
Adolescent
56
2026
10168
0.650
Why?
Steroids
12
2011
168
0.640
Why?
Diagnostic Imaging
4
2014
468
0.640
Why?
Recurrence
22
2020
1274
0.630
Why?
Patient Selection
8
2011
725
0.630
Why?
Competency-Based Education
1
2020
37
0.630
Why?
C-Reactive Protein
14
2022
219
0.620
Why?
Global Health
5
2011
216
0.610
Why?
Precancerous Conditions
4
2016
221
0.610
Why?
Psychopathology
1
2019
31
0.600
Why?
alpha-Fetoproteins
1
2019
48
0.580
Why?
Carcinoma, Squamous Cell
1
2026
1107
0.580
Why?
Diet
4
2021
472
0.580
Why?
Administration, Oral
18
2016
677
0.580
Why?
Time-to-Treatment
1
2020
163
0.560
Why?
Gastrointestinal Tract
2
2014
198
0.560
Why?
Follow-Up Studies
23
2026
4049
0.560
Why?
Chronic Disease
10
2022
991
0.540
Why?
Conflict of Interest
3
2009
76
0.540
Why?
Purines
1
2018
97
0.540
Why?
Disease Progression
8
2026
1621
0.530
Why?
Health Care Costs
3
2009
269
0.520
Why?
Primary Prevention
2
2008
93
0.510
Why?
Antineoplastic Agents, Immunological
1
2020
238
0.500
Why?
Ulcer
3
2006
38
0.490
Why?
Vitamin D Deficiency
3
2016
118
0.490
Why?
Interleukin-23
1
2017
63
0.490
Why?
Drug Approval
2
2007
68
0.490
Why?
Anti-Ulcer Agents
4
2005
22
0.490
Why?
Food
3
2021
93
0.480
Why?
Prognosis
20
2020
4139
0.470
Why?
Sigmoidoscopy
11
2015
36
0.470
Why?
Gastrointestinal Hemorrhage
4
2020
251
0.470
Why?
Cholangitis, Sclerosing
5
2020
59
0.470
Why?
Enema
7
2008
37
0.470
Why?
Risk Factors
22
2021
6295
0.470
Why?
Trichuris
2
2013
2
0.460
Why?
Proctocolectomy, Restorative
2
2012
119
0.450
Why?
Enterocolitis
2
2022
13
0.440
Why?
Granulocytes
2
2012
34
0.430
Why?
Wound Healing
8
2020
385
0.430
Why?
Blood Component Removal
2
2012
29
0.430
Why?
Infusions, Intravenous
15
2016
403
0.430
Why?
Delayed-Action Preparations
9
2016
125
0.420
Why?
History, 20th Century
5
2012
323
0.420
Why?
Academic Medical Centers
2
2009
416
0.420
Why?
Metabolic Syndrome
2
2006
126
0.410
Why?
Pneumonia
2
2015
195
0.410
Why?
Clinical Competence
3
2020
873
0.410
Why?
Monocytes
4
2012
219
0.410
Why?
Patient Satisfaction
5
2011
519
0.400
Why?
Delivery of Health Care
2
2009
483
0.400
Why?
Diverticulitis
1
2013
10
0.400
Why?
Societies, Medical
2
2015
687
0.400
Why?
Intestinal Polyps
2
2008
27
0.390
Why?
Therapy with Helminths
1
2013
1
0.390
Why?
Antigens, Helminth
1
2013
20
0.390
Why?
Tacrolimus
3
2011
376
0.390
Why?
Research Design
7
2024
652
0.390
Why?
Diverticulum
1
2013
45
0.380
Why?
Ovum
1
2013
61
0.380
Why?
Ileostomy
3
2012
28
0.380
Why?
Antimetabolites
4
2011
22
0.380
Why?
Life Style
3
2008
193
0.370
Why?
Thioguanine
5
2018
17
0.370
Why?
Radiation Injuries
2
2014
160
0.370
Why?
Treatment Refusal
3
2011
69
0.370
Why?
Hospitalization
6
2024
993
0.360
Why?
Obesity
4
2008
1079
0.360
Why?
Population Surveillance
5
2016
218
0.360
Why?
Allergens
1
2013
196
0.360
Why?
Surgical Stomas
1
2012
22
0.360
Why?
Carnitine
1
2012
15
0.360
Why?
Colonic Polyps
2
2018
143
0.350
Why?
Intestinal Fistula
5
2016
32
0.350
Why?
History, 21st Century
4
2012
196
0.350
Why?
Colonic Diseases, Functional
3
2003
3
0.340
Why?
Biological Factors
3
2019
18
0.340
Why?
Health Promotion
3
2008
175
0.340
Why?
Biomarkers, Tumor
3
2019
1786
0.330
Why?
Postoperative Complications
8
2018
2719
0.330
Why?
Vitamins
2
2016
93
0.330
Why?
Disease Outbreaks
2
2009
149
0.330
Why?
Physicians
2
2009
687
0.330
Why?
Pregnancy
12
2019
3286
0.330
Why?
Biopsy
11
2020
1226
0.320
Why?
Endoscopy, Gastrointestinal
7
2013
171
0.320
Why?
Case-Control Studies
16
2023
2017
0.320
Why?
Hypertension, Portal
1
2010
46
0.320
Why?
Leukapheresis
3
2008
16
0.320
Why?
Neutrophils
3
2024
346
0.320
Why?
Otitis Media
1
2010
20
0.310
Why?
Cephalosporins
1
2010
25
0.310
Why?
Health Behavior
2
2009
203
0.310
Why?
Education, Medical, Continuing
2
2011
100
0.300
Why?
Prednisolone
3
2018
38
0.300
Why?
Inflammation
7
2023
1134
0.300
Why?
Self Disclosure
1
2009
29
0.300
Why?
Peptic Ulcer
1
2009
18
0.300
Why?
Proctitis
2
2000
12
0.300
Why?
Esophagitis
1
2009
40
0.300
Why?
Specialization
1
2010
69
0.300
Why?
Safety Management
1
2009
54
0.300
Why?
Surveys and Questionnaires
12
2026
3058
0.300
Why?
Outsourced Services
1
2009
1
0.290
Why?
Consumer Product Safety
1
2009
12
0.290
Why?
Commerce
1
2009
30
0.290
Why?
Proton Pump Inhibitors
1
2009
36
0.290
Why?
Body Temperature Regulation
1
2009
60
0.290
Why?
Financial Support
1
2009
7
0.290
Why?
Food Contamination
1
2009
39
0.290
Why?
Ileum
8
2025
179
0.290
Why?
Food Supply
1
2009
34
0.290
Why?
Uncertainty
2
2021
81
0.290
Why?
Adipose Tissue, Brown
1
2009
98
0.280
Why?
Sulfapyridine
1
2008
2
0.280
Why?
Abdominal Pain
2
2007
149
0.280
Why?
Muscle Hypotonia
1
2009
47
0.280
Why?
Jet Lag Syndrome
1
2008
13
0.280
Why?
Drug Delivery Systems
2
2007
202
0.270
Why?
Happiness
1
2008
13
0.270
Why?
Histamine Antagonists
1
2008
14
0.270
Why?
Periodicals as Topic
1
2010
175
0.270
Why?
Risk Reduction Behavior
1
2008
102
0.270
Why?
Task Performance and Analysis
1
2008
91
0.270
Why?
Self Efficacy
1
2008
65
0.270
Why?
Prednisone
8
2007
252
0.270
Why?
Behavior
1
2008
86
0.260
Why?
Marketing
1
2008
24
0.260
Why?
Fasting
1
2008
166
0.260
Why?
Ileal Diseases
2
2004
24
0.260
Why?
Legislation as Topic
1
2007
3
0.260
Why?
Clinical Trials, Phase I as Topic
1
2008
154
0.260
Why?
Measles-Mumps-Rubella Vaccine
1
2007
9
0.260
Why?
Prevalence
6
2022
1396
0.260
Why?
Cost-Benefit Analysis
4
2021
521
0.260
Why?
Prospective Studies
20
2024
4837
0.260
Why?
Immunity, Innate
2
2014
482
0.260
Why?
Simethicone
1
2007
1
0.260
Why?
Flatulence
1
2007
2
0.260
Why?
Gastroesophageal Reflux
1
2009
131
0.260
Why?
Antirheumatic Agents
4
2011
67
0.260
Why?
Retreatment
5
2016
106
0.260
Why?
Diagnosis, Differential
8
2010
1571
0.260
Why?
Health Priorities
1
2007
31
0.260
Why?
Terminology as Topic
2
2011
226
0.260
Why?
Gastrointestinal Motility
1
2007
26
0.250
Why?
Quality of Health Care
2
2012
400
0.250
Why?
Feces
4
2021
392
0.250
Why?
Nutritional Physiological Phenomena
1
2007
27
0.250
Why?
Animals
16
2025
29045
0.250
Why?
Liver Diseases
2
2008
250
0.250
Why?
Nutrition Assessment
1
2007
23
0.250
Why?
Neoplasms
5
2024
3382
0.250
Why?
Economic Competition
1
2006
12
0.250
Why?
Ethics, Medical
1
2009
292
0.250
Why?
Energy Metabolism
1
2009
314
0.250
Why?
Insemination, Artificial, Homologous
1
2006
3
0.250
Why?
Retrospective Studies
24
2020
11104
0.250
Why?
Patents as Topic
1
2006
12
0.250
Why?
Ovulation Induction
1
2006
29
0.250
Why?
Phosphodiesterase Inhibitors
1
2006
30
0.240
Why?
Abdominal Abscess
2
2016
25
0.240
Why?
Drugs, Generic
1
2006
21
0.240
Why?
Occupational Health
1
2007
41
0.240
Why?
Immunity
1
2008
160
0.240
Why?
Nobel Prize
1
2006
10
0.240
Why?
Observation
1
2006
38
0.240
Why?
Autistic Disorder
1
2007
157
0.240
Why?
Contraceptives, Oral
3
1991
49
0.240
Why?
Infertility
1
2006
36
0.240
Why?
United States Food and Drug Administration
1
2007
165
0.240
Why?
Health Expenditures
1
2007
118
0.240
Why?
Biodiversity
1
2009
252
0.240
Why?
Self Concept
1
2007
141
0.240
Why?
Integrins
3
2021
83
0.240
Why?
Pandemics
2
2022
923
0.240
Why?
Thiazoles
1
2006
127
0.240
Why?
Vibrio Infections
1
2005
2
0.230
Why?
Genetics
1
2006
25
0.230
Why?
Disease Management
4
2018
378
0.230
Why?
Circadian Rhythm
1
2008
295
0.230
Why?
Natalizumab
7
2013
21
0.230
Why?
Gastroenteritis
1
2005
26
0.230
Why?
Cell Transformation, Neoplastic
2
2010
466
0.230
Why?
Private Practice
1
2005
12
0.230
Why?
Climate
1
2005
63
0.220
Why?
Spermatozoa
2
2022
68
0.220
Why?
Symptom Assessment
3
2020
77
0.220
Why?
Ethics Committees, Research
1
2005
34
0.220
Why?
Nitriles
1
2026
172
0.220
Why?
Foodborne Diseases
1
2005
9
0.220
Why?
Unemployment
1
2005
13
0.220
Why?
Intestine, Small
6
2021
321
0.220
Why?
Researcher-Subject Relations
1
2005
4
0.220
Why?
Human Experimentation
1
2005
41
0.220
Why?
Journalism, Medical
1
2004
6
0.220
Why?
Aged, 80 and over
12
2019
7461
0.220
Why?
Hyperbaric Oxygenation
1
2024
14
0.210
Why?
Peer Review
1
2004
20
0.210
Why?
Pregnancy Complications
3
2004
371
0.210
Why?
Stress, Psychological
1
2008
384
0.210
Why?
Ultrasonography
2
2018
722
0.210
Why?
Rectal Fistula
3
2014
21
0.210
Why?
Stem Cell Transplantation
1
2006
196
0.210
Why?
HLA-DR Antigens
1
2004
58
0.210
Why?
Triggering Receptor Expressed on Myeloid Cells-1
1
2024
1
0.210
Why?
Ileitis
3
2011
7
0.210
Why?
HLA-DQ Antigens
1
2004
52
0.210
Why?
Dietary Supplements
1
2005
152
0.210
Why?
Disability Evaluation
1
2005
185
0.210
Why?
Pain
2
2023
417
0.210
Why?
Intestines
3
2020
442
0.200
Why?
Acute Disease
9
2011
864
0.200
Why?
Serum Albumin
2
2019
126
0.200
Why?
MicroRNAs
4
2021
609
0.200
Why?
Cecal Diseases
1
2003
5
0.200
Why?
Cell- and Tissue-Based Therapy
2
2015
65
0.200
Why?
Vagus Nerve Stimulation
1
2023
12
0.200
Why?
Feeding Behavior
1
2007
354
0.200
Why?
Enterocolitis, Pseudomembranous
3
2011
52
0.200
Why?
Career Choice
1
2005
167
0.200
Why?
Congresses as Topic
3
2010
125
0.200
Why?
Stents
1
2007
442
0.200
Why?
Adenocarcinoma
3
2018
1215
0.200
Why?
Aging
1
2009
772
0.200
Why?
Osteoporosis
1
2005
138
0.200
Why?
Organ Transplantation
1
2007
307
0.200
Why?
Lactoferrin
1
2003
10
0.200
Why?
DNA Breaks, Double-Stranded
2
2021
73
0.200
Why?
Lupus Vulgaris
1
2003
4
0.190
Why?
Intracellular Signaling Peptides and Proteins
4
2010
405
0.190
Why?
Employment
1
2004
67
0.190
Why?
Fetus
1
2004
239
0.190
Why?
Lung Diseases
1
2005
284
0.190
Why?
Patient Reported Outcome Measures
2
2024
337
0.190
Why?
Fibroblast Growth Factors
1
2003
89
0.190
Why?
Adjuvants, Immunologic
4
2009
177
0.190
Why?
Clinical Trials, Phase III as Topic
2
2018
172
0.180
Why?
Education, Medical
1
2005
233
0.180
Why?
Anus Diseases
2
2003
16
0.180
Why?
Adipose Tissue
1
2005
280
0.180
Why?
Polymorphism, Genetic
2
2025
832
0.180
Why?
Calcineurin Inhibitors
2
2013
55
0.180
Why?
Placenta
2
2015
202
0.180
Why?
Incidence
8
2020
1798
0.180
Why?
Pentanoic Acids
1
2002
7
0.180
Why?
Cycloserine
1
2001
5
0.180
Why?
Chicago
4
2018
1520
0.170
Why?
Carbohydrates
1
2021
40
0.170
Why?
Administration, Topical
4
2016
80
0.170
Why?
DNA End-Joining Repair
1
2021
7
0.170
Why?
Interleukin-12
1
2021
110
0.170
Why?
Analgesics, Opioid
1
2026
546
0.170
Why?
CD3 Complex
3
2014
137
0.170
Why?
Symptom Flare Up
2
2021
12
0.170
Why?
Language
1
2022
165
0.170
Why?
Genetic Predisposition to Disease
9
2010
2588
0.160
Why?
Graft Rejection
1
2007
1189
0.160
Why?
Phenylhydrazines
5
2005
9
0.160
Why?
Mycophenolic Acid
1
2001
90
0.160
Why?
Cell Adhesion Molecules
3
2024
186
0.160
Why?
Chemoprevention
3
2006
93
0.160
Why?
DNA
3
2022
1274
0.160
Why?
Leukocyte L1 Antigen Complex
4
2023
52
0.160
Why?
Graft vs Host Disease
1
2022
382
0.150
Why?
Pyridines
1
2002
317
0.150
Why?
Logistic Models
5
2006
1276
0.150
Why?
Erythrocyte Count
1
2019
21
0.150
Why?
Genetic Linkage
5
2002
613
0.150
Why?
Hematocrit
1
2019
68
0.150
Why?
Erythema Nodosum
2
2006
4
0.150
Why?
Ipilimumab
1
2020
69
0.150
Why?
Thalidomide
1
1999
57
0.150
Why?
Forecasting
3
2008
298
0.150
Why?
Pouchitis
2
2012
58
0.150
Why?
Platelet Count
1
2019
94
0.150
Why?
CTLA-4 Antigen
1
2020
147
0.150
Why?
Psoriasis
1
2022
262
0.150
Why?
Neurons
1
2008
1634
0.150
Why?
Blood Proteins
1
2019
147
0.140
Why?
Lymphoproliferative Disorders
1
1999
105
0.140
Why?
Indoles
3
2009
340
0.140
Why?
Hemoglobins
1
2019
197
0.140
Why?
Long-Term Care
4
2017
69
0.140
Why?
Gastrointestinal Microbiome
3
2023
663
0.140
Why?
Sensitivity and Specificity
3
2010
1946
0.140
Why?
Rectum
6
2011
152
0.140
Why?
Interleukin-6
2
2017
283
0.140
Why?
Genomic Instability
1
2019
92
0.140
Why?
Retroperitoneal Neoplasms
1
1998
42
0.140
Why?
Treatment Failure
4
2014
300
0.140
Why?
Programmed Cell Death 1 Receptor
1
2020
201
0.140
Why?
Stomatitis, Aphthous
1
1998
4
0.140
Why?
Autoimmune Diseases
2
2002
262
0.140
Why?
Cardiovascular Diseases
1
2005
824
0.140
Why?
Prostatic Neoplasms
2
2020
1846
0.140
Why?
Pyoderma Gangrenosum
1
1998
21
0.130
Why?
Aspirin
1
2019
168
0.130
Why?
Fecal Incontinence
2
2008
62
0.130
Why?
Menstrual Cycle
1
1998
84
0.130
Why?
Thrombospondins
1
2017
15
0.130
Why?
Caveolin 1
1
2017
24
0.130
Why?
Parenteral Nutrition, Total
4
2005
41
0.130
Why?
Colonic Diseases
3
2006
60
0.130
Why?
B7-H1 Antigen
1
2020
333
0.130
Why?
Antibody Formation
2
2011
173
0.130
Why?
Lymphoma, B-Cell
1
1998
110
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2021
2666
0.130
Why?
Paternal Exposure
1
2017
4
0.130
Why?
Child
11
2013
7771
0.130
Why?
Reproducibility of Results
6
2024
2799
0.130
Why?
Standard of Care
1
2018
71
0.130
Why?
Meta-Analysis as Topic
2
2009
87
0.130
Why?
Pilot Projects
7
2013
978
0.130
Why?
Collagen Type I
1
2017
75
0.130
Why?
Legislation, Drug
2
2007
7
0.130
Why?
Cohort Studies
4
2019
3242
0.120
Why?
Focal Adhesions
1
2017
67
0.120
Why?
Injections, Intravenous
4
2018
215
0.120
Why?
Protein-Losing Enteropathies
1
1996
6
0.120
Why?
Practice Patterns, Physicians'
2
2016
669
0.120
Why?
Fertility
1
2017
120
0.120
Why?
Drug Synergism
2
2007
317
0.120
Why?
Drug Design
1
2017
136
0.120
Why?
Cross-Over Studies
3
2009
394
0.120
Why?
Leukoencephalopathy, Progressive Multifocal
2
2014
8
0.120
Why?
Prostate-Specific Antigen
1
2018
356
0.120
Why?
United Kingdom
3
2020
217
0.120
Why?
Tumor Microenvironment
1
2021
621
0.120
Why?
Placebo Effect
2
2014
37
0.120
Why?
Receptors, Calcitriol
2
2016
130
0.120
Why?
Guidelines as Topic
2
2007
169
0.120
Why?
Algorithms
4
2014
2005
0.120
Why?
Receptors, Lysosphingolipid
1
2016
38
0.120
Why?
Nod2 Signaling Adaptor Protein
4
2010
15
0.120
Why?
Digestive System Fistula
3
2010
4
0.120
Why?
Drug Combinations
2
2007
202
0.120
Why?
Lymphoma, Large B-Cell, Diffuse
1
1998
197
0.120
Why?
Reactive Oxygen Species
1
2019
526
0.120
Why?
Clinical Decision-Making
1
2018
306
0.120
Why?
Transition to Adult Care
1
2016
29
0.120
Why?
Chi-Square Distribution
3
2007
361
0.120
Why?
Interleukin-12 Subunit p40
1
2015
12
0.110
Why?
Clinical Medicine
1
2015
27
0.110
Why?
Smoking Cessation
3
2012
310
0.110
Why?
Chromosomes, Human, Pair 16
3
2000
79
0.110
Why?
Integrin alpha4
3
2013
11
0.110
Why?
Monitoring, Physiologic
3
2012
265
0.110
Why?
Lymphocytes
2
2015
461
0.110
Why?
Autoantibodies
1
1996
286
0.110
Why?
Cell Migration Inhibition
1
2014
8
0.110
Why?
Digestive System Surgical Procedures
3
2005
153
0.110
Why?
T-Lymphocytes
4
2023
1335
0.100
Why?
Fistula
1
2014
44
0.100
Why?
Drug Substitution
1
2014
30
0.100
Why?
Radiation Protection
1
2014
28
0.100
Why?
Oxides
1
2014
42
0.100
Why?
Postoperative Period
3
2016
325
0.100
Why?
Aminosalicylic Acid
1
2013
1
0.100
Why?
Calcineurin
1
2013
20
0.100
Why?
Radiation, Ionizing
1
2014
123
0.100
Why?
Endoscopy
3
2013
388
0.100
Why?
Intestinal Obstruction
3
2006
99
0.100
Why?
Transcriptome
2
2026
828
0.100
Why?
Pulmonary Embolism
1
1996
235
0.100
Why?
Radiography, Thoracic
1
2015
331
0.100
Why?
Acute Kidney Injury
1
2018
361
0.100
Why?
Carbon
1
2014
99
0.100
Why?
Cholangitis
1
1993
19
0.100
Why?
Probiotics
2
2008
99
0.100
Why?
Mucous Membrane
1
2013
83
0.100
Why?
Vaginal Fistula
1
1993
5
0.100
Why?
Observer Variation
4
2018
579
0.100
Why?
Ciprofloxacin
1
2013
24
0.100
Why?
Enteritis
1
2013
23
0.090
Why?
Occupational Exposure
1
2014
102
0.090
Why?
Methyltransferases
3
2011
220
0.090
Why?
Pneumonia, Pneumocystis
1
1992
18
0.090
Why?
Defecation
2
2009
26
0.090
Why?
Gastritis
1
2013
38
0.090
Why?
Sickness Impact Profile
2
2011
29
0.090
Why?
Body Weight
1
2013
457
0.090
Why?
Sigmoid Diseases
1
1992
4
0.090
Why?
Intestinal Pseudo-Obstruction
1
1992
7
0.090
Why?
Bacterial Infections
2
2006
184
0.090
Why?
Abatacept
1
2012
90
0.090
Why?
Guanine Nucleotides
1
2011
13
0.090
Why?
Thionucleotides
1
2011
54
0.090
Why?
Quality Indicators, Health Care
1
2013
158
0.080
Why?
Cytomegalovirus
1
2011
74
0.080
Why?
Phenotype
5
2021
2673
0.080
Why?
Proto-Oncogenes
1
2011
60
0.080
Why?
Tomography, X-Ray Computed
2
2015
2680
0.080
Why?
Attitude
1
2012
134
0.080
Why?
Carcinoma
2
1995
442
0.080
Why?
Immunoconjugates
1
2012
140
0.080
Why?
Age Factors
4
2007
1976
0.080
Why?
Odds Ratio
5
2003
728
0.080
Why?
Delphi Technique
2
2025
183
0.080
Why?
Chromosomes, Human, Pair 3
2
2002
55
0.080
Why?
Capsules
6
2002
39
0.080
Why?
Reference Values
2
2018
608
0.080
Why?
Enzyme Inhibitors
1
2013
641
0.080
Why?
Patient Acuity
2
2020
38
0.080
Why?
Cytomegalovirus Infections
1
2011
116
0.080
Why?
Liver
3
2011
1231
0.080
Why?
Analysis of Variance
4
2002
890
0.080
Why?
Receptors, Tumor Necrosis Factor
2
2001
85
0.080
Why?
Writing
1
2010
27
0.080
Why?
Mexico
1
2010
76
0.080
Why?
Leukemia, Myeloid
3
1995
241
0.080
Why?
Editorial Policies
1
2010
37
0.080
Why?
Interleukin-10
2
2000
167
0.080
Why?
Cross-Cultural Comparison
1
2009
36
0.080
Why?
Folic Acid Deficiency
1
1989
6
0.080
Why?
Gene Expression Profiling
3
2026
1572
0.070
Why?
Photopheresis
1
2009
12
0.070
Why?
Rad51 Recombinase
2
2021
81
0.070
Why?
Predictive Value of Tests
3
2024
1792
0.070
Why?
Folic Acid
1
1989
68
0.070
Why?
Canada
1
2009
210
0.070
Why?
Carrier Proteins
2
2003
670
0.070
Why?
Clinical Protocols
2
2004
156
0.070
Why?
Spiro Compounds
1
2009
24
0.070
Why?
Chromosomes, Human, Pair 1
2
2000
107
0.070
Why?
Reoperation
1
2012
730
0.070
Why?
Ghrelin
1
2009
31
0.070
Why?
Maximum Tolerated Dose
3
2015
265
0.070
Why?
Insurance, Health, Reimbursement
1
2009
57
0.070
Why?
Drug Interactions
1
2009
240
0.070
Why?
Parenteral Nutrition
2
1986
63
0.070
Why?
Cytochrome P-450 CYP3A
1
2008
41
0.070
Why?
Chromosome Mapping
4
2006
1064
0.070
Why?
Autoimmunity
1
2010
195
0.070
Why?
Feasibility Studies
3
2007
818
0.070
Why?
Muscular Atrophy
1
2009
49
0.070
Why?
Immunoglobulin G
2
2001
481
0.070
Why?
Data Interpretation, Statistical
2
2016
312
0.070
Why?
Body Composition
1
2009
88
0.070
Why?
Haplotypes
2
2008
657
0.070
Why?
Wine
1
2008
6
0.070
Why?
Insulin-Like Growth Factor I
1
2009
118
0.070
Why?
Interferon-beta
1
2009
127
0.070
Why?
Preventive Medicine
1
2008
19
0.070
Why?
Psychology, Social
1
2008
8
0.070
Why?
Cell Proliferation
1
2014
1801
0.070
Why?
Decision Support Techniques
1
2010
193
0.070
Why?
Glycoproteins
1
1989
222
0.070
Why?
Curcumin
1
2008
18
0.070
Why?
Taste
1
2008
29
0.070
Why?
Video Recording
3
2015
217
0.070
Why?
Rifamycins
1
2007
7
0.070
Why?
Lupus Erythematosus, Systemic
1
2010
244
0.070
Why?
Growth
1
2007
42
0.060
Why?
Cisapride
1
2007
4
0.060
Why?
Domperidone
1
2007
7
0.060
Why?
Tablets
1
2009
137
0.060
Why?
HCT116 Cells
2
2021
164
0.060
Why?
Thiazolidinediones
1
2007
76
0.060
Why?
Antifoaming Agents
1
2007
1
0.060
Why?
Leukocyte Count
3
2003
215
0.060
Why?
Digestive System Physiological Phenomena
1
2007
4
0.060
Why?
Nutritional Requirements
1
2007
17
0.060
Why?
Salicylates
2
1999
25
0.060
Why?
Food Service, Hospital
1
2007
4
0.060
Why?
Taxes
1
2007
6
0.060
Why?
Cyclophosphamide
3
1996
285
0.060
Why?
Tumor Necrosis Factors
1
2007
14
0.060
Why?
Gases
1
2007
31
0.060
Why?
Vaccination
1
2009
328
0.060
Why?
Antigens, Neoplasm
1
1989
366
0.060
Why?
3',5'-Cyclic-AMP Phosphodiesterases
1
2006
9
0.060
Why?
Organizations
1
2007
18
0.060
Why?
Computers, Handheld
1
2007
34
0.060
Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2006
10
0.060
Why?
Gastrointestinal Transit
1
2007
20
0.060
Why?
Intercellular Signaling Peptides and Proteins
1
2008
197
0.060
Why?
Narration
1
2007
23
0.060
Why?
Survival Analysis
3
2004
1530
0.060
Why?
Pregnancy Rate
1
2006
18
0.060
Why?
Cytotoxins
1
1986
18
0.060
Why?
Intestinal Perforation
1
2007
39
0.060
Why?
Metronidazole
2
2000
26
0.060
Why?
Cyclooxygenase 2 Inhibitors
1
2006
36
0.060
Why?
Neoplasm Grading
2
2018
425
0.060
Why?
Health Facilities
1
2007
43
0.060
Why?
Intestinal Absorption
1
2007
125
0.060
Why?
Adsorption
1
2006
52
0.060
Why?
Constipation
1
2007
69
0.060
Why?
Preoperative Care
1
1989
420
0.060
Why?
Medical Records
1
2007
124
0.060
Why?
Health Status Indicators
1
2006
99
0.060
Why?
Energy Intake
1
2006
100
0.060
Why?
Endoscopy, Digestive System
3
2001
76
0.060
Why?
Sample Size
1
2006
130
0.060
Why?
New Zealand
1
2026
24
0.060
Why?
Fat Emulsions, Intravenous
1
1986
15
0.060
Why?
Helicobacter Infections
1
2006
36
0.060
Why?
Mass Screening
2
2008
753
0.060
Why?
North America
3
2014
211
0.060
Why?
Helicobacter pylori
1
2006
36
0.060
Why?
Regression Analysis
4
2010
578
0.060
Why?
Vibrio parahaemolyticus
1
2005
2
0.060
Why?
Longitudinal Studies
3
2000
1305
0.060
Why?
Ostreidae
1
2005
3
0.060
Why?
Alaska
1
2005
22
0.060
Why?
Health Education
1
2006
110
0.060
Why?
Jews
2
2003
42
0.060
Why?
Bacterial Toxins
1
1986
112
0.060
Why?
Emotions
1
2009
388
0.060
Why?
Integrin alpha Chains
1
2005
21
0.060
Why?
Sirolimus
1
2007
181
0.060
Why?
Patient Care
1
2007
100
0.060
Why?
Recombinant Proteins
4
2000
994
0.060
Why?
Nuclear Proteins
1
2010
757
0.060
Why?
Chemistry, Pharmaceutical
1
2006
79
0.060
Why?
Viscera
1
2005
19
0.060
Why?
Laos
1
2005
4
0.060
Why?
Consensus
1
2007
308
0.060
Why?
Mice
4
2024
12762
0.060
Why?
Antineoplastic Agents, Alkylating
2
1996
136
0.060
Why?
Illinois
1
2007
531
0.060
Why?
Pancreatitis
1
1986
108
0.060
Why?
Histocytochemistry
2
2017
122
0.060
Why?
Polymorphism, Single Nucleotide
3
2010
2577
0.060
Why?
Paclitaxel
1
2007
484
0.060
Why?
Mesenteric Veins
1
2005
38
0.050
Why?
Recombinant Fusion Proteins
2
1997
557
0.050
Why?
Needs Assessment
1
2026
174
0.050
Why?
Cells, Cultured
3
2015
2859
0.050
Why?
Equipment Design
1
2006
428
0.050
Why?
Kaplan-Meier Estimate
3
2013
909
0.050
Why?
Pregnancy Trimester, Third
1
2004
72
0.050
Why?
Combined Modality Therapy
4
1999
1754
0.050
Why?
HLA-DRB1 Chains
1
2004
24
0.050
Why?
Fatty Liver
1
2006
122
0.050
Why?
Pancreatic Diseases
1
2024
62
0.050
Why?
Matrix Metalloproteinase 14
1
2024
5
0.050
Why?
Mucoproteins
1
2024
21
0.050
Why?
Diagnostic Errors
1
2005
161
0.050
Why?
Pain Management
1
2026
198
0.050
Why?
Lymphocyte Count
1
2024
99
0.050
Why?
Absenteeism
1
2004
10
0.050
Why?
Qualitative Research
1
2026
424
0.050
Why?
Lymphocyte Subsets
1
2024
71
0.050
Why?
Research Subjects
1
2005
80
0.050
Why?
Linkage Disequilibrium
2
2008
484
0.050
Why?
Confidence Intervals
3
1994
221
0.050
Why?
Clinical Trials, Phase II as Topic
1
2004
168
0.050
Why?
Fever
1
2004
123
0.050
Why?
Structure-Activity Relationship
1
2004
429
0.050
Why?
Drainage
1
2004
176
0.050
Why?
Risk
3
2011
662
0.050
Why?
Fibroblast Growth Factor 10
1
2003
7
0.050
Why?
Primary Health Care
1
2007
408
0.050
Why?
Proportional Hazards Models
3
2018
925
0.050
Why?
Bone Density
1
2005
249
0.050
Why?
Probability
1
2004
356
0.050
Why?
Administration, Intravenous
1
2023
64
0.050
Why?
Cell Cycle Proteins
1
2006
420
0.050
Why?
Exercise
1
2007
384
0.050
Why?
Etanercept
2
2001
37
0.050
Why?
Saccharomyces cerevisiae Proteins
1
2006
310
0.050
Why?
Infant
1
2010
3368
0.050
Why?
T-Lymphocytes, Regulatory
1
2026
358
0.050
Why?
Therapeutic Equivalency
1
2022
16
0.050
Why?
Lymphocyte Activation
1
2006
825
0.050
Why?
Informed Consent
1
2005
281
0.050
Why?
Body Mass Index
1
2006
869
0.050
Why?
Leukemia, Monocytic, Acute
1
1982
9
0.050
Why?
Venous Thrombosis
1
2005
265
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2003
374
0.050
Why?
Multivariate Analysis
2
2020
1007
0.040
Why?
Syndrome
1
2003
444
0.040
Why?
ROC Curve
1
2024
797
0.040
Why?
Antibodies, Antinuclear
3
2007
94
0.040
Why?
Methylprednisolone
1
2022
65
0.040
Why?
Age of Onset
4
2007
369
0.040
Why?
Neovascularization, Pathologic
1
2024
356
0.040
Why?
Purpura, Thrombotic Thrombocytopenic
1
2002
21
0.040
Why?
Patient Compliance
4
2007
247
0.040
Why?
Survival Rate
3
2011
2057
0.040
Why?
Plasma Exchange
1
2002
28
0.040
Why?
Lod Score
4
2006
152
0.040
Why?
Sex Factors
1
2005
1144
0.040
Why?
Intention to Treat Analysis
1
2021
82
0.040
Why?
Frameshift Mutation
1
2001
50
0.040
Why?
Ku Autoantigen
1
2021
15
0.040
Why?
Bradycardia
1
2021
52
0.040
Why?
Leukemia, Hairy Cell
1
1981
73
0.040
Why?
Aftercare
1
2022
93
0.040
Why?
Real-Time Polymerase Chain Reaction
2
2013
301
0.040
Why?
Cyclosporins
1
2001
56
0.040
Why?
Folic Acid Antagonists
1
2000
17
0.040
Why?
Statistics, Nonparametric
2
1999
304
0.040
Why?
Peristalsis
1
2000
10
0.040
Why?
Coculture Techniques
1
2021
175
0.040
Why?
Suppositories
1
2000
4
0.040
Why?
Down-Regulation
2
2013
529
0.040
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2021
90
0.040
Why?
Decision Making
1
2006
691
0.040
Why?
Bacterial Proteins
1
1986
901
0.040
Why?
Adaptation, Psychological
1
2021
190
0.040
Why?
Genetic Markers
3
2013
471
0.040
Why?
Chemical and Drug Induced Liver Injury
1
2000
68
0.040
Why?
Mice, Inbred C57BL
2
2021
3628
0.040
Why?
Salvage Therapy
2
2013
241
0.040
Why?
Gene Expression
1
2024
1322
0.040
Why?
Data Collection
2
1999
376
0.040
Why?
Databases, Genetic
1
2021
290
0.040
Why?
Interleukin-11
1
1999
20
0.040
Why?
Suture Techniques
1
2000
142
0.040
Why?
Cutaneous Fistula
1
1999
10
0.040
Why?
Machine Learning
1
2023
413
0.040
Why?
Hospitals
1
2022
351
0.040
Why?
Xenograft Model Antitumor Assays
1
2021
559
0.040
Why?
Hematopoietic Stem Cell Transplantation
2
1996
979
0.040
Why?
Gene Expression Regulation, Neoplastic
2
2017
1400
0.040
Why?
Electromyography
1
1999
233
0.040
Why?
Chromosomes, Human, Pair 12
1
1998
64
0.040
Why?
Health Services
1
1999
55
0.040
Why?
Patient Discharge
1
2022
385
0.030
Why?
Proctocolitis
1
1998
3
0.030
Why?
Chromosomes, Human, Pair 4
1
1998
45
0.030
Why?
Immunotherapy
1
2024
831
0.030
Why?
Genetic Variation
2
2006
1460
0.030
Why?
Reference Standards
1
2018
147
0.030
Why?
Fatal Outcome
1
1998
295
0.030
Why?
Transfection
2
2010
884
0.030
Why?
Lipopolysaccharides
2
2014
313
0.030
Why?
Cost of Illness
1
1998
165
0.030
Why?
Monitoring, Ambulatory
1
1997
32
0.030
Why?
Epistasis, Genetic
1
1998
95
0.030
Why?
Opportunistic Infections
1
2017
57
0.030
Why?
Constriction, Pathologic
2
2006
214
0.030
Why?
Breast Neoplasms
3
1996
3303
0.030
Why?
Homeodomain Proteins
1
2021
568
0.030
Why?
Fatty Acids, Volatile
1
1997
35
0.030
Why?
Lipoxygenase Inhibitors
1
1997
36
0.030
Why?
Comorbidity
1
2000
1037
0.030
Why?
Interleukin-3
1
1996
39
0.030
Why?
Quinolines
1
1997
97
0.030
Why?
International Agencies
1
2016
35
0.030
Why?
Occludin
1
2016
66
0.030
Why?
Diphenhydramine
1
1996
15
0.030
Why?
Interleukin-8
1
2016
90
0.030
Why?
Antibodies, Antineutrophil Cytoplasmic
1
1996
23
0.030
Why?
Zonula Occludens-1 Protein
1
2016
70
0.030
Why?
Histamine H1 Antagonists
1
1996
39
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
114
0.030
Why?
Prostaglandin Antagonists
1
1995
7
0.030
Why?
NF-kappa B
2
2013
424
0.030
Why?
Mice, Knockout
1
2021
2217
0.030
Why?
Proteins
1
2001
804
0.030
Why?
Activities of Daily Living
1
2016
214
0.030
Why?
Immunity, Cellular
1
1996
187
0.030
Why?
Hypertension
1
2021
791
0.030
Why?
Enteral Nutrition
1
1996
103
0.030
Why?
Pregnancy Outcome
1
2017
285
0.030
Why?
Single-Blind Method
1
2015
160
0.030
Why?
Cadherins
1
2016
189
0.030
Why?
Databases, Factual
1
1999
1102
0.030
Why?
Phytohemagglutinins
1
2014
20
0.030
Why?
Signal Transduction
2
2017
3642
0.030
Why?
Antigens, CD
1
2016
482
0.030
Why?
Israel
1
2014
69
0.030
Why?
Minnesota
1
1994
64
0.030
Why?
Polymerase Chain Reaction
2
2010
895
0.030
Why?
Administration, Cutaneous
1
1994
66
0.030
Why?
Interleukin-1beta
1
2014
92
0.030
Why?
CD28 Antigens
1
2014
94
0.030
Why?
Microspheres
1
2014
99
0.030
Why?
Hematopoietic Stem Cells
1
1996
330
0.020
Why?
Trinitrobenzenesulfonic Acid
1
2013
16
0.020
Why?
Dextran Sulfate
1
2013
73
0.020
Why?
Area Under Curve
1
2014
341
0.020
Why?
Gene Frequency
2
2008
716
0.020
Why?
Discriminant Analysis
1
2013
64
0.020
Why?
Group Processes
1
2013
30
0.020
Why?
Radiation Dosage
1
2014
233
0.020
Why?
Tobacco Smoke Pollution
1
1993
26
0.020
Why?
Adaptive Immunity
1
2014
194
0.020
Why?
Hydrocortisone
1
1994
305
0.020
Why?
Apoptosis Regulatory Proteins
1
2013
201
0.020
Why?
DNA, Complementary
1
2013
380
0.020
Why?
Transcriptional Activation
1
2013
293
0.020
Why?
Tertiary Care Centers
1
2013
131
0.020
Why?
Tight Junctions
1
2013
158
0.020
Why?
Aneuploidy
1
1992
60
0.020
Why?
Polymorphism, Restriction Fragment Length
1
2012
145
0.020
Why?
Suspensions
1
2011
6
0.020
Why?
Myelodysplastic Syndromes
1
1995
386
0.020
Why?
Medication Adherence
1
2013
130
0.020
Why?
Anastomosis, Surgical
1
2013
291
0.020
Why?
Tumor Suppressor Proteins
1
2013
318
0.020
Why?
Regional Blood Flow
1
2011
194
0.020
Why?
Interdisciplinary Communication
1
2012
137
0.020
Why?
Metagenome
1
2012
123
0.020
Why?
RNA, Ribosomal, 16S
1
2012
270
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2013
700
0.020
Why?
In Situ Hybridization
1
2011
306
0.020
Why?
Polymethacrylic Acids
1
1990
3
0.020
Why?
Tobacco Use Disorder
1
2012
130
0.020
Why?
Chewing Gum
1
1990
4
0.020
Why?
Sentinel Surveillance
1
2010
23
0.020
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2010
18
0.020
Why?
Up-Regulation
1
2013
742
0.020
Why?
Polyvinyls
1
1990
32
0.020
Why?
Patient Safety
1
2013
237
0.020
Why?
Statistics as Topic
1
2011
229
0.020
Why?
Protein Structure, Quaternary
1
2010
105
0.020
Why?
Immunoprecipitation
1
2010
140
0.020
Why?
Immunoblotting
1
2010
273
0.020
Why?
Mice, Transgenic
1
2013
1608
0.020
Why?
Blotting, Western
1
2011
779
0.020
Why?
Methoxsalen
1
2009
15
0.020
Why?
Quality Improvement
1
2014
538
0.020
Why?
Epithelial Cells
1
2013
710
0.020
Why?
Interferon beta-1a
1
2009
18
0.020
Why?
Photosensitizing Agents
1
2009
53
0.020
Why?
Cecum
1
1989
78
0.020
Why?
Evaluation Studies as Topic
1
1989
244
0.020
Why?
Immunoenzyme Techniques
1
1989
291
0.020
Why?
Motivation
1
2012
344
0.020
Why?
Electrolytes
1
1988
52
0.020
Why?
Immunohistochemistry
1
2013
1818
0.020
Why?
Midazolam
1
2008
49
0.020
Why?
Headache
1
2009
80
0.020
Why?
Rabbits
2
2005
582
0.020
Why?
Japan
1
2008
306
0.020
Why?
Registries
1
1993
1133
0.020
Why?
Anal Canal
1
1988
94
0.020
Why?
Apoptosis
1
2013
1754
0.020
Why?
Cross-Sectional Studies
1
2013
2077
0.020
Why?
Nod1 Signaling Adaptor Protein
1
2006
2
0.010
Why?
Emulsions
1
1986
20
0.010
Why?
Stomach Diseases
1
2006
18
0.010
Why?
Sacroiliac Joint
1
2006
14
0.010
Why?
Rectal Diseases
1
2006
25
0.010
Why?
Duodenal Diseases
1
2006
26
0.010
Why?
Esophageal Diseases
1
2006
26
0.010
Why?
Uveitis
1
2006
35
0.010
Why?
JC Virus
1
2005
5
0.010
Why?
Influenza, Human
1
2009
358
0.010
Why?
Endpoint Determination
1
2005
65
0.010
Why?
Short Bowel Syndrome
1
2005
38
0.010
Why?
Liver Function Tests
1
1985
95
0.010
Why?
RNA, Messenger
1
2011
2076
0.010
Why?
Tissue Culture Techniques
1
2005
81
0.010
Why?
Minority Groups
1
2006
166
0.010
Why?
Drug Tolerance
1
2004
59
0.010
Why?
Intestine, Large
1
1984
15
0.010
Why?
Random Allocation
1
2005
312
0.010
Why?
Diverticulum, Colon
1
1984
11
0.010
Why?
Campylobacter Infections
1
1984
12
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2006
316
0.010
Why?
DNA-Binding Proteins
1
2010
1275
0.010
Why?
Models, Animal
1
2005
282
0.010
Why?
Drug Hypersensitivity
1
1984
38
0.010
Why?
CD4-Positive T-Lymphocytes
1
2007
507
0.010
Why?
Physical Examination
1
1984
149
0.010
Why?
CD8-Positive T-Lymphocytes
1
2007
701
0.010
Why?
Software
1
2007
698
0.010
Why?
Radiography
1
1984
763
0.010
Why?
Cell Line, Tumor
1
2008
2913
0.010
Why?
Clostridium Infections
1
1984
132
0.010
Why?
Length of Stay
2
1996
889
0.010
Why?
Genome-Wide Association Study
1
2010
1863
0.010
Why?
Blastomycosis
1
1981
6
0.010
Why?
DNA Mutational Analysis
1
2003
554
0.010
Why?
Anticoagulants
1
2005
486
0.010
Why?
Mycobacterium Infections
1
1981
11
0.010
Why?
Cellulitis
1
1981
17
0.010
Why?
Splenectomy
1
1981
50
0.010
Why?
Hepatitis
1
1981
32
0.010
Why?
Thyroxine
1
1984
411
0.010
Why?
Homozygote
1
2001
213
0.010
Why?
I-kappa B Proteins
1
2000
47
0.010
Why?
Abscess
1
1981
94
0.010
Why?
Mutagenesis, Insertional
1
2001
103
0.010
Why?
Injections
1
2001
131
0.010
Why?
Patient Dropouts
1
2000
33
0.010
Why?
Middle East
1
2000
19
0.010
Why?
Physical Chromosome Mapping
1
2000
26
0.010
Why?
Injections, Intramuscular
1
2000
63
0.010
Why?
Patient Education as Topic
1
2004
419
0.010
Why?
Cytosine
1
2001
124
0.010
Why?
Heterozygote
1
2001
393
0.010
Why?
Family Health
1
2000
157
0.010
Why?
International Cooperation
1
2000
133
0.010
Why?
Protein Structure, Tertiary
1
2001
733
0.010
Why?
Lymphoma
1
1981
255
0.010
Why?
In Situ Hybridization, Fluorescence
1
2000
369
0.010
Why?
Pedigree
1
2000
988
0.010
Why?
Erythrocytes
1
1999
242
0.010
Why?
Alleles
1
2001
1163
0.010
Why?
Amino Acid Sequence
1
2001
2011
0.010
Why?
Base Sequence
1
2001
2224
0.010
Why?
Disease Models, Animal
1
2005
2581
0.010
Why?
Disease Susceptibility
1
1998
225
0.010
Why?
Leukotriene B4
1
1997
16
0.010
Why?
Molecular Sequence Data
1
2001
2897
0.010
Why?
Cell Line
1
2001
2484
0.010
Why?
Colony-Forming Units Assay
1
1996
39
0.010
Why?
Blood Cells
1
1996
32
0.010
Why?
Bone Marrow Diseases
1
1996
38
0.010
Why?
Thiotepa
1
1996
32
0.010
Why?
Life Tables
1
1996
46
0.010
Why?
Premedication
1
1996
57
0.010
Why?
Thrombophlebitis
1
1995
24
0.010
Why?
Melphalan
1
1996
98
0.010
Why?
Surgical Wound Dehiscence
1
1995
38
0.010
Why?
Doxorubicin
1
1996
285
0.010
Why?
Karyotyping
1
1995
220
0.010
Why?
Insurance Selection Bias
1
1995
1
0.010
Why?
Leukemia, Myeloid, Acute
1
1981
850
0.010
Why?
Bone Marrow Transplantation
1
1996
287
0.010
Why?
Substance Withdrawal Syndrome
1
1995
55
0.010
Why?
Fluorouracil
1
1996
543
0.010
Why?
Chromosome Aberrations
1
1995
353
0.010
Why?
Genotype
1
1998
1895
0.010
Why?
Palliative Care
1
1996
291
0.010
Why?
Disease-Free Survival
1
1996
1196
0.010
Why?
Surgical Wound Infection
1
1995
252
0.010
Why?
Orosomucoid
1
1991
1
0.010
Why?
Antineoplastic Agents
1
1981
2386
0.000
Why?
Cyclic GMP
1
1988
63
0.000
Why?
Cyclic AMP
1
1988
277
0.000
Why?
Infant, Newborn
1
1993
2556
0.000
Why?
Alanine Transaminase
1
1985
74
0.000
Why?
Aspartate Aminotransferases
1
1985
74
0.000
Why?
Alkaline Phosphatase
1
1985
129
0.000
Why?
Bilirubin
1
1985
135
0.000
Why?
Blastomyces
1
1981
3
0.000
Why?
B-Lymphocytes
1
1983
737
0.000
Why?
Skin
1
1981
592
0.000
Why?
Hanauer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (947)
Explore
_
Co-Authors (39)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_